Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 3 10Phase NA 7Phase 1 4Phase 2/3 3Phase 1/2 2

Status

Not yet recruiting 2Completed 1

Sponsor Class

UNKNOWN 1OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 3Breast Neoplasms 3Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms 1Inflammatory Breast Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 5Oxaliplatin 4Surgical Procedures, Operative 3Radiotherapy 3Neoadjuvant Therapy 3Leucovorin 3Drug Therapy 3Chemoradiotherapy 3Capecitabine 3Irinotecan 2Immune Checkpoint Inhibitors 2Folfox protocol 2Bevacizumab 2sulindac sulfone 1sintilimab 1XELOX 1Water 1Surveys and Questionnaires 1Preoperative Exercise 1Photochemotherapy 1N-dihydrogalactochitosan 1Microwaves 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Leucine-tRNA Ligase 1Injections 1Indocyanine Green 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Rectal Neoplasms × Neoadjuvant Therapy × Clear all
NCT07134218 2025-08-21

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

Changhai Hospital

Phase 2/3 Not yet recruiting
180 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05484024 2022-08-02

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

ChineseAMS

Phase 2/3 Not yet recruiting
588 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01086618 2013-08-26

Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Completed
500 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡